Pharmaceutical Technology
JULY 28, 2022
FDI experts at Investment Monitor have highlighted the following list of factors as most important to life sciences companies considering a greenfield investment in 2022: labour, education, industry clusters, domestic market, infrastructure, business environment, costs and quality of life. appeared first on Pharmaceutical Technology.
European Pharmaceutical Review
NOVEMBER 9, 2023
According to the BSI, all manufacturers of these products are eligible for the AMR certification to gain the BSI Kitemark , which involves an initial evaluation against the requirements of a designated international standard, published in June 2022.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
OCTOBER 6, 2023
Eur.) , Japanese Pharmacopoeia (JP), and the US Pharmacopeia (USP) in 1989. Thus, a key aim for the PDG is to harmonise select pharmacopoeial standards.
European Pharmaceutical Review
AUGUST 10, 2023
Amidst numerous warning letters distributed by the US Food and Drug Administration (FDA) to pharmaceutical manufacturers in recent months, in July this year, the US regulatory body published its analysis on drug product quality in 2022. In subsequent years, up to 2022, half this number or less were issued.
Pharma Marketing Network
JANUARY 18, 2023
Bob is a life sciences and technology marketing leader with more than 25 years of experience working directly for pharmaceutical manufacturers (Merck, AstraZeneca, and Shire) and for technology companies that serve the industry (Appature, IQVIA, and Sparta).
European Pharmaceutical Review
JUNE 6, 2023
BSI, a UK standards body, developed the new certification to the Antibiotic Manufacturing Standard published in June 2022.
PM360
DECEMBER 20, 2023
Given China’s status as the world’s second most populous nation and an economic powerhouse, it represents both a monumental market opportunity and a dynamic arena of challenges for pharmaceutical products. From 2017 to 2022, the Chinese market witnessed a growth rate of 5.3%, compared to the average market growth of 6.6% in the U.S.
Expert insights. Personalized for you.
52 
Let's personalize your content